Viewing Study NCT00251004

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:16 PM
Ignite Modification Date: 2026-03-20 @ 8:07 PM
Study NCT ID: NCT00251004
Status: COMPLETED
Last Update Posted: 2011-05-10
First Post: 2005-11-07
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients
Sponsor: Novartis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Transplantation View
None Graft Rejection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Renal transplantation, kidney, and organ transplant View
None Renal transplant rejection View